Prot #R668-AD-1314: A Randomized, Double-Blind, Placebo-Controlled, Study Investigating Vaccine Responses in Adults with Moderate to Severe Atopic Dermatitis Treated with Dupilumab

  • Gordon, Kenneth B (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/9/14 → 10/9/17

Funding

  • Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1314)